Fatty Liver: all 1,462 studies
Page 3 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )Not yet recruitingNCT05790057
- Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusRecruitingNCT05779644Not applicable
- Risk Factors for Hepatic Inflammation, Fibrosis and Prognosis in Patients With CHB and NAFLDRecruitingNCT05766449
- Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 AnalogueRecruitingNCT05751720Phase 1/2
- Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver DiseaseNot yet recruitingNCT05738707
- Using Hydroxychloroquine to Treat Nonalcoholic SteatohepatitisRecruitingNCT05733897
- Comparative Clinical Study to Evaluate the Efficacy and Safety of Rosuvastatin Vs CoQ10 on Nonalcoholic SteatohepatitisNot yet recruitingNCT05731596Phase 3
- A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver CancerRecruitingNCT05719480
- Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes MellitusRecruitingNCT05697991
- COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCERRecruitingNCT05692024Phase 1/2
- CT Liver Fat Fraction QuantificationEnrolling by invitationNCT05676177Not applicable
- Global Research Initiative for Patients Screening on MASHRecruitingNCT05651724
- A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)RecruitingNCT05648214Phase 1/2
- Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric BypassRecruitingNCT05640947Not applicable
- HuHuangLianzonggan Capsule in Subjects With Nonalcoholic Steatohepatitis: a Phase 2 tRial(HHL-HEPAR)RecruitingNCT05632861Phase 2
- Observational Study About Patients Diagnosed With NAFLDRecruitingNCT05625750
- Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic SteatohepatitisNot yet recruitingNCT05622526Phase 2
- Prevention of NAFLD and CVD Through Lifestyle InterventionRecruitingNCT05618626Not applicable
- Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of ChinaRecruitingNCT05597709
- Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver DiseaseEnrolling by invitationNCT05563259
- Metabolic Subtypes of Non-Alcoholic Fatty Liver DiseaseRecruitingNCT05560997
- Integrated Multi-omics Data for Personalized Treatment of Obesity-associated Fatty Liver DiseaseRecruitingNCT05554224
- The Effect of Bariatric Surgery on Hepatic Metabolism in Non-Alcoholic Fatty Liver DiseaseEnrolling by invitationNCT05551559Not applicable
- BeijngFH Health Cohort StudyRecruitingNCT05546086
- Fructose and Liver Diseases in Youth: Help Them FLYRecruitingNCT05528471Not applicable
- The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric RestrictionRecruitingNCT05499702Phase 2
- Gastric Bypass Stent Small-Sample-Size Study For Nonalcoholic Fatty Liver DiseaseRecruitingNCT05495139Not applicable
- Soluble Fibre Supplementation in NAFLDRecruitingNCT05480696Phase 2
- Beneficial Effects of Dietary and Lifestyle Change in Overweight and Obese SubjectsNot yet recruitingNCT05447351
- The Effect of Vegetarian Diet on Patients With Metabolic Associated Fatty Liver DiseaseRecruitingNCT05443581Not applicable
- PreDEA Study, Prevention in Emergency / Acceptance Departments: the Case of Hepatic SteatosisRecruitingNCT05436860
- Metabolic Pathology of Pediatric NAFLDRecruitingNCT05430178Not applicable
- The Relationship Between Long-term Oral Anti Hepatitis B Nucleoside Analogs and Hepatic SteatosisEnrolling by invitationNCT05416008
- An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic SteatosisRecruitingNCT05335603
- Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver DiseaseRecruitingNCT05309863
- Fully Automated High-Throughput Quantitative MRI of the LiverRecruitingNCT05294471
- Gut Permeability and Bariatric-metabolic SurgeryRecruitingNCT05257200
- A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease.RecruitingNCT05255978
- Impact of Time-restricted Feeding in NAFLDRecruitingNCT05220956Not applicable
- Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin ResistanceRecruitingNCT05165706Not applicable
- Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2DNot yet recruitingNCT05140694Phase 4
- Estimation of Steatosis on Liver Transplants by Intraoperative SpectrometryRecruitingNCT05106322
- Norursodeoxycholic Acid vs. Placebo in NASHRecruitingNCT05083390Phase 2
- Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)RecruitingNCT05029583Not applicable
- Impact of Cold Exposure on Metabolic Regulation in Children With Non Alcoholic Fatty Liver Disease (NAFLD)RecruitingNCT04969744Not applicable
- THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)Not yet recruitingNCT04925362Not applicable
- NAFLD Primary CareRecruitingNCT04918732Not applicable
- Intermittent Fasting for NAFLD in AdultsRecruitingNCT04899102Not applicable
- Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver DiseaseRecruitingNCT04873258
- AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)RecruitingNCT04807868
- Interest in "Combo" (a Combination of Dietary Supplements Including Probiotics) in NASH ImprovementRecruitingNCT04781933Not applicable
- Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy DrinkersRecruitingNCT04781322Phase 1
- Role of Regulatory B Cells in the Pathogenesis of Metabolic Associated Fatty Liver DiseaseRecruitingNCT04720560
- Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)RecruitingNCT04697810Phase 2
- Sex Differences in Myocardial Steatosis Induced Left Ventricular DysfunctionRecruitingNCT04671966Phase 4
- A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in ChinaRecruitingNCT04573283
- Multicenter Registry of Nonalcoholic Fatty Liver DiseaseNot yet recruitingNCT04540731
- Low-Dose Pioglitazone in Patients With NASH (AIM 2)RecruitingNCT04501406Phase 2
- The European NAFLD RegistryRecruitingNCT04442334
- PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesRecruitingNCT04371042
- Fatty Liver Disease in Nordic CountriesRecruitingNCT04340817
- Genetic Pathways Leading to Fatty Liver and Atherogenic DyslipidemiaEnrolling by invitationNCT04209816
- European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)RecruitingNCT04190849
- the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.RecruitingNCT04104282
- Prevalence of Advanced Fibrosis in Patients Living With HIVEnrolling by invitationNCT04066608
- Effect of Polyphenol Supplementation on Hepatic Steatosis and Vascular ComplianceRecruitingNCT03994029Not applicable
- Lifestyle Modification Programme for HIV-infected Individuals With Fatty LiverRecruitingNCT03913351Not applicable
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)RecruitingNCT03884075Phase 2
- Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style InterventionRecruitingNCT03875625Not applicable
- Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and HypogonadismRecruitingNCT03851627Phase 4
- Liver Disease in PregnancyRecruitingNCT03834285
- Cold-induced Brown Fat Activation and Hepatic SteatosisRecruitingNCT03811236Not applicable
- China Health Big DataRecruitingNCT03699228
- Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver DiseaseRecruitingNCT03635541
- Prognostic Significance of Fatty Liver Disease in Bariatric PatientsRecruitingNCT03535142Not applicable
- Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 DiabetesRecruitingNCT03525769
- Early Tracking of Childhood Health Determinants (ETCHED) StudyRecruitingNCT03481829
- Disease Prevention in Clinical Practice Base on Patient Specific PhysiologyEnrolling by invitationNCT03308773
- Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in ChineseNot yet recruitingNCT03282305
- A Prospective, Randomized, Open Label Trial of Two Doses of Oral BetaineRecruitingNCT03073343Not applicable
- Blood Collection Biorepository for Liver Disease ResearchRecruitingNCT03025074
- Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)RecruitingNCT02663388
- Low Calorie Diet and DiabetesEnrolling by invitationNCT02498990Not applicable
- Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver DiseaseRecruitingNCT02422238
- Fatty Liver Patient RegistryRecruitingNCT02298439
- The Influence of Autophagy on Fatty LiverRecruitingNCT01988441
- Congenital Muscle Disease Study of Patient and Family Reported Medical InformationRecruitingNCT01403402
- The Danish Childhood Obesity BiobankRecruitingNCT00928473Not applicable
- Prospective Cohort Study in Patients With NAFLDRecruitingNCT00575133
- A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4TerminatedNCT07052682Phase 1Results posted
- Intermittent Fasting and Metabolic Dysfunction Associated Fatty Liver DiseaseCompletedNCT06664684Not applicableResults posted
- Conditionally Increased Output (CIO) Enhanced Ultrasound SystemCompletedNCT05792423Not applicableResults posted
- A Study in Participants With Non-cirrhotic NASH With FibrosisCompletedNCT05638737Phase 2Results posted
- The Effects of Glucagon on Hepatic MetabolismCompletedNCT05500586Phase 1/2Results posted
- DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic SteatohepatitisCompletedNCT05415722Phase 2Results posted
- The University of Michigan Wellness for Liver Health StudyCompletedNCT05010070Phase 1/2Results posted
- A Study of Efinopegdutide (MK-6024) in Participants With Nonalcoholic Fatty Liver Disease (NAFLD) (MK-6024-001)CompletedNCT04944992Phase 2Results posted
- Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)CompletedNCT04929483Phase 2Results posted
- Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)CompletedNCT04906421Phase 2Results posted
- AVIATION Study: A Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy Study of TERN-201 in Patients With Non-Cirrhotic Non-Alcoholic SteatohepatitisCompletedNCT04897594Phase 1Results posted